Log in

Pro-Dex Stock Price, News & Analysis (NASDAQ:PDEX)

$13.58
-0.03 (-0.22 %)
(As of 10/17/2019 06:30 AM ET)
Today's Range
$13.21
Now: $13.58
$13.65
50-Day Range
$13.49
MA: $14.55
$15.75
52-Week Range
$8.01
Now: $13.58
$17.95
Volume3,848 shs
Average Volume8,548 shs
Market Capitalization$54.18 million
P/E Ratio17.28
Dividend YieldN/A
Beta1.52
Pro-Dex, Inc., together with its subsidiaries, designs, develops, and manufactures powered surgical instruments, dental instruments, and rotary air motors worldwide. It also manufactures plastic injection molds for various industries; and shavers and machined parts. In addition, it provides engineering, and quality and regulatory consulting services. The company offers its products under the name of Pro-Dex.Pro-Dex, Inc. sells its medical device products primarily to original equipment manufacturers; and dental products to dental product distributors. Its products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PDEX
CUSIPN/A
Phone949-769-3200

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$27.17 million
Cash Flow$1.11 per share
Book Value$4.14 per share

Profitability

Net Income$4.15 million

Miscellaneous

Employees80
Market Cap$54.18 million
Next Earnings Date11/14/2019 (Estimated)
OptionableNot Optionable

Receive PDEX News and Ratings via Email

Sign-up to receive the latest news and ratings for PDEX and its competitors with MarketBeat's FREE daily newsletter.


Pro-Dex (NASDAQ:PDEX) Frequently Asked Questions

What is Pro-Dex's stock symbol?

Pro-Dex trades on the NASDAQ under the ticker symbol "PDEX."

How were Pro-Dex's earnings last quarter?

Pro-Dex Inc (NASDAQ:PDEX) issued its quarterly earnings data on Thursday, August, 30th. The medical instruments supplier reported $0.22 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.06 by $0.16. Pro-Dex had a net margin of 15.32% and a return on equity of 24.02%. View Pro-Dex's Earnings History.

When is Pro-Dex's next earnings date?

Pro-Dex is scheduled to release their next quarterly earnings announcement on Thursday, November 14th 2019. View Earnings Estimates for Pro-Dex.

What price target have analysts set for PDEX?

1 equities research analysts have issued 1 year price targets for Pro-Dex's stock. Their forecasts range from $20.00 to $20.00. On average, they anticipate Pro-Dex's stock price to reach $20.00 in the next year. This suggests a possible upside of 47.3% from the stock's current price. View Analyst Price Targets for Pro-Dex.

What is the consensus analysts' recommendation for Pro-Dex?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Pro-Dex in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Pro-Dex.

Has Pro-Dex been receiving favorable news coverage?

News coverage about PDEX stock has been trending very negative this week, InfoTrie Sentiment reports. The research group identifies negative and positive press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Pro-Dex earned a coverage optimism score of -3.2 on InfoTrie's scale. They also gave media stories about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Pro-Dex.

Are investors shorting Pro-Dex?

Pro-Dex saw a decline in short interest in the month of September. As of September 30th, there was short interest totalling 11,000 shares, a decline of 5.2% from the August 30th total of 11,600 shares. Based on an average trading volume of 14,600 shares, the days-to-cover ratio is presently 0.8 days. Currently, 0.4% of the shares of the stock are short sold. View Pro-Dex's Current Options Chain.

Who are some of Pro-Dex's key competitors?

What other stocks do shareholders of Pro-Dex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pro-Dex investors own include KEMET (KEM), Micron Technology (MU), NovaBay Pharmaceuticals (NBY), Innovative Industrial Properties (IIPR), Magnachip Semiconductor (MX), Amtech Systems (ASYS), Alphabet (GOOG), Amarin (AMRN), Athersys (ATHX) and Aware (AWRE).

Who are Pro-Dex's key executives?

Pro-Dex's management team includes the folowing people:
  • Mr. Richard Lee Van Kirk Jr., CEO, Pres, COO & Director (Age 58)
  • Mrs. Alisha K. Charlton, CFO & Corp. Sec. (Age 49)

How do I buy shares of Pro-Dex?

Shares of PDEX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Pro-Dex's stock price today?

One share of PDEX stock can currently be purchased for approximately $13.58.

How big of a company is Pro-Dex?

Pro-Dex has a market capitalization of $54.18 million and generates $27.17 million in revenue each year. Pro-Dex employs 80 workers across the globe.View Additional Information About Pro-Dex.

What is Pro-Dex's official website?

The official website for Pro-Dex is http://www.pro-dex.com/.

How can I contact Pro-Dex?

Pro-Dex's mailing address is 2361 MCGAW AVENUE, IRVINE CA, 92614. The medical instruments supplier can be reached via phone at 949-769-3200 or via email at [email protected]


MarketBeat Community Rating for Pro-Dex (NASDAQ PDEX)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  78 (Vote Outperform)
Underperform Votes:  91 (Vote Underperform)
Total Votes:  169
MarketBeat's community ratings are surveys of what our community members think about Pro-Dex and other stocks. Vote "Outperform" if you believe PDEX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PDEX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/17/2019 by MarketBeat.com Staff

Featured Article: What is a blue-chip stock?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel